HK Stock Market Move | Insurance stocks are collectively rebounding, with total assets in the insurance industry surpassing 42 trillion RMB. Institutions believe that the equity market warming up will likely increase profits.
Insurance stocks collectively rebounded. As of the time of writing, New China Insurance (01336) rose 3.25% to HK $49.56; China Life Insurance (02628) rose 2.77% to HK $29.72; China Pacific Insurance (02601) rose 1.18% to HK $35.54; China Property Insurance (02328) rose 1.01% to HK $14.93.
Insurance stocks have collectively rebounded, as of the time of writing, New China Life Insurance (01336) rose 3.25% to HK$49.56; China Life Insurance (02628) rose 2.77% to HK$29.72; China Pacific Insurance (02601) rose 1.18% to HK$35.54; PICC P&C (02328) rose 1.01% to HK$14.93.
In terms of news, the China Banking and Insurance Regulatory Commission released data on the main regulatory indicators of the banking and insurance industries in the first quarter of 2026. By the end of the first quarter of 2026, the total assets of insurance companies and insurance asset management companies were RMB 42.5 trillion, an increase of 2.8% compared to the beginning of the year. In addition, in the first quarter of 2026, the insurance industry achieved premium income of RMB 2.31 trillion, an increase of 6.2% year-on-year.
China Securities Co., Ltd. released a research report stating that deposit migration and the "anti-insular" policy are expected to drive faster growth in liabilities, and the warming of the equity market since April is expected to increase profits. The current valuation has a relatively high safety margin. Huaxi also stated that the demand in the insurance market remains strong due to deposit migration, and the transformation of dividend insurance will help alleviate pressure on interest rate differentials, leading to an improvement in the industry's business climate. Currently, active funds are still under-allocated to the insurance sector.
Related Articles

SOFTCARE (02698) non-executive director Yang Yanjuan increased his holdings by a total of 876,400 shares.

BOAN BIOTECH (06955): Darzalex Injection Bolgajay granted new indication in China for the treatment of solid tumor bone metastasis and multiple myeloma.

China Railway Construction Corporation (01186) has issued 3 billion yuan of corporate bonds for technology innovation.
SOFTCARE (02698) non-executive director Yang Yanjuan increased his holdings by a total of 876,400 shares.

BOAN BIOTECH (06955): Darzalex Injection Bolgajay granted new indication in China for the treatment of solid tumor bone metastasis and multiple myeloma.

China Railway Construction Corporation (01186) has issued 3 billion yuan of corporate bonds for technology innovation.






